Fusemachines Regains Nasdaq Listing Rule Compliance
Fusemachines confirmed it regained Nasdaq compliance with its minimum market value rule on July 7, 2026, allowing for continued listing. This notice resolves past delisting concern…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Fusemachines confirmed it regained Nasdaq compliance with its minimum market value rule on July 7, 2026, allowing for continued listing. This notice resolves past delisting concern…
Keenova Therapeutics announced positive results from a Phase 3 clinical trial for XIAFLEX, demonstrating significant pain relief and functional improvement. The company plans to su…
GameStop Corp. has approved a Certificate of Amendment increasing its authorized capital stock to 2.505 billion shares. This expansion grants the company additional flexibility for…
The Federal Reserve Board is requesting public comment on a proposal to amend existing requirements for banks to maintain anti-money laundering programs.
Deloitte & Touche submitted a commentary regarding ONE Group's July 8-K filing. This regulatory disclosure highlights the auditor's disagreement with specific statements made withi…
Intapp and its investors entered into a restated registration rights agreement to replace a prior version.
The company filed an exhibit regarding Bureau of Land Management assignments, a routine regulatory submission indicating compliance with land-related documentation requirements wit…
Olaplex Holdings filed a second amended and restated certificate of incorporation in Delaware to authorize 1,000 shares of common stock. This filing updates corporate governance an…
BIO-key International announced its shares will resume trading on Nasdaq starting July 8, following a panel's decision that the company has regained compliance with listing require…
Theriva Biologics obtained regulatory authorization from the Spanish Agency for the VIRAGE2 clinical trial testing increased VCN-01 dosing in metastatic pancreatic cancer. This stu…
Aptera Motors received an EPA Certificate of Conformity for its 2026 Launch Edition, confirming emissions compliance for U.S. sale. This regulatory milestone brings the company clo…
Tvardi announced positive Phase 1 results for its STAT3 prodrug TTI-109, demonstrating target engagement and significantly improved tolerability compared to the parent compound. Th…
Polomar Health Services filed updated amended and restated bylaws to define shareholder meetings and board authority. This document update is a routine governance measure with no i…
Dell Technologies Inc. filed amended and restated bylaws effective July 1, 2026. This regulatory filing updates the company's internal governance procedures and voting rules.
The company filed an amendment to its Articles of Incorporation as Exhibit 3.1. This regulatory action typically signifies a change in corporate governance or authorized capital st…
Invivyd confirmed the FDA will terminate the Emergency Use Authorization for PEMGARDA on June 29, 2027. Although the company intends to pursue permanent approval, the eventual loss…
W. P. Carey Inc. entered into a supplemental indenture dated July 2, 2026 to amend its 2014 debt indenture. This legal document updates the terms regarding the issuance of unsecure…
ABVC Biopharma addressed the SEC to validate the auditor change disclosed in its July 1, 2026 8-K. This documentation signifies compliance with procedural requirements for accounti…
PIMCO Asset-Based Lending reports a net asset value of $10.31 per share as of May 31, 2026. Total equity reached $523.97 million across all outstanding share classes.
The Federal Reserve issued an enforcement action against Small Business Bank. The Board also terminated enforcement actions against BNP Paribas entities and Community Bankshares, I…